NCT05259488 is a clinical trial of immunonutrition in Gastric Cancer, sponsored by University of Rome Tor Vergata.

Who is sponsoring NCT05259488?

NCT05259488 is sponsored by University of Rome Tor Vergata.

What drugs are being tested in NCT05259488?

Interventions in NCT05259488: immunonutrition.

What condition does NCT05259488 study?

NCT05259488 studies Gastric Cancer, Surgery, Laparoscopic, Gastric Neoplasm, Digestive Cancer.

Is NCT05259488 still recruiting?

NCT05259488 is currently completed. Last updated 28 February 2022.

Last reviewed 2022-02-28 · How we verify

NCT05259488

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Preoperative Immunonutrition in Laparoscopic Total D2 Gastrectomy

Completed Last updated 28 February 2022

What this trial tests

trial testing immunonutrition in Gastric Cancer in 51 participants. Completed in 1 January 2022.

Timeline

1 January 2014

Primary endpoint
31 December 2021

1 January 2022

Quick facts

Lead sponsor	University of Rome Tor Vergata
Status	Completed
Study type	OBSERVATIONAL
Enrollment	51
Start date	1 January 2014
Primary completion	31 December 2021
Estimated completion	1 January 2022

Drugs / interventions tested

immunonutrition — full drug profile →

Conditions studied

Gastric Cancer — all drugs for Gastric Cancer →
Surgery — all drugs for Surgery →
Laparoscopic — all drugs for Laparoscopic →
Gastric Neoplasm — all drugs for Gastric Neoplasm →

Sponsor

University of Rome Tor Vergata

Who can join

18 and older, any sex, with Gastric Cancer or Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Immunonutrition (IN) appears to reduce infective complications and in-hospital length of stay (LOS) after gastrointestinal surgery. More specifically, it seems to be beneficial also in gastric cancer surgery. Potential benefits of combining preoperative IN (PIN) with protocols of enhanced recovery after surgery (ERAS) in reducing LOS in laparoscopic total gastrectomy are yet to be determined.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Immunonutrition reduces complications rate and length of stay after laparoscopic total gastrectomy: a single unit retrospective study.
Franceschilli M, Siragusa L, Usai V, Dhimolea S, et al · · 2022 · cited 7× · PMID 35816241 · DOI 10.1007/s12672-022-00490-5

Verify or expand the search:

Other trials of immunonutrition

Trials testing the same drug.

NCT05679661 — Perioperative Immunonutrition Intervention and Oral Decontamination in Elderly Surgical Patients · NA · recruiting

Other recruiting trials for Gastric Cancer

Currently open trials in the same condition.

NCT07525765 — AI-assisted Decision-making of Reoperation for Postoperative Bleeding of Gastric Cancer · recruiting
NCT07464470 — Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Gastroesophageal Cancers · recruiting
NCT07432633 — [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications · Phase 1, PHASE2 · recruiting
NCT07431281 — Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Meta · Phase 3 · recruiting
NCT07448493 — Local Treatment Strategies for Brain Metastases of Gastric and Esophageal Cancer · active not recruiting

Other University of Rome Tor Vergata trials

Trials by the same sponsor.

NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
NCT07313358 — 10119473 -VIROMARKERS HDV Biomarkers Study · not yet recruiting
NCT07286461 — VIROMARKERS GA n.101194735 - CMV and TTV Biomarkers Study Protocol · not yet recruiting
NCT07067749 — Treatment Expedition With MRI Processing and Optimization for Muscle Invasive Bladder Cancer · Phase 3 · recruiting
NCT06711744 — ISQ Differences Between Different Implants in Post-extraction Sockets · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05259488 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Rome Tor Vergata
Last refreshed: 28 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05259488.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing